Furthermore, SLC7A11 degradation leads to the decline of GSH and imbalance of cellular redox characterized by total ROS and lipid ROS accumulation, eventually resulting in ferroptosis and growth inhibition of HCC cells (Figure 6). The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.